1. Home
  2. ADAM vs AURA Comparison

ADAM vs AURA Comparison

Compare ADAM & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ADAM

Adamas Trust Inc.

HOLD

Current Price

$8.43

Market Cap

826.7M

Sector

Technology

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.02

Market Cap

797.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAM
AURA
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
826.7M
797.5M
IPO Year
2003
2021

Fundamental Metrics

Financial Performance
Metric
ADAM
AURA
Price
$8.43
$6.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$9.17
$20.00
AVG Volume (30 Days)
921.1K
616.2K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
11.87%
N/A
EPS Growth
196.49
N/A
EPS
0.87
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.08
N/A
P/E Ratio
$10.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.45
$4.73
52 Week High
$10.36
$9.54

Technical Indicators

Market Signals
Indicator
ADAM
AURA
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
ADAM
AURA

About ADAM Adamas Trust Inc.

Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: